Suraksha Diagnostic Ltd

NSE: SURAKSHA | BSE: 544293

₹323.75

up-down-arrow-4.10 (-1.25%)

As on 11-Sep-2026IST

Market cap

info icon

₹1,688 Cr

Revenue (TTM)

info icon

₹325 Cr

P/E Ratio

info icon

47.1

P/B Ratio

info icon

6.6

Div. Yield

info icon

0.2 %

Value Research Rating

Quality Score fund-quick-summary-circle

Quality Score9/10

Growth Score fund-quick-summary-circle

Growth Score4/10

Valuation Score fund-quick-summary-circle

Valuation Score5/10

Momentum Score fund-quick-summary-circle

Momentum Score8/10

Suraksha Diagnostic Share Price

Compare

High: Low: Return:

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 318.10 High: 330.10

52 Week Range

Low: 224.10 High: 349.00

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹36 Cr

  • ROEROE information

    13.8 %

  • ROCEROCE information

    25 %

  • Industry P/EIndustry P/E information

    60.28

  • EV/EBITDAEV/EBITDA information

    15.8

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    ₹49.3

  • EPSEPS information

    ₹6.9

  • Face valueFace value information

    2

  • Shares outstandingShares outstanding information

    52,080,758

10 Years Aggregate

CFO

₹387.79 Cr

EBITDA

₹482.76 Cr

Net Profit

₹166.90 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Suraksha Diagnostic
20.1 21.9 19.6 5.5 -- -- --
BSE Healthcare
18.0 0.1 9.1 14.7 21.9 14.1 11.9
As on 11-Sep-2026
Company
2025
Suraksha Diagnostic
-29.1
BSE Small Cap
-6.6
BSE Healthcare
-3.3

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Suraksha Diagnostic
323.8 1,687.7 325.5 35.1 18.1 15.1 47.1 6.6
1,909.0 32,049.1 2,890.8 546.3 23.0 23 59.1 12.3
1,447.2 38,920.5 4,683.4 552.3 15.6 14.9 70 9.5
769.0 32,292.2 4,212.5 190.8 11.9 9.4 158.1 8.5
550.1 1,792.2 815.3 97.5 14.9 10.2 18.4 1.8
585.5 12,154.7 1,710.0 202.8 16.8 14.1 60.3 7.8
1,438.2 16,613.0 1,445.7 164.1 -- 15.4 99.7 11.7
765.4 7,708.4 998.9 76.8 -- 9.2 100.3 6.8
549.7 8,727.0 876.0 174.0 25.3 32.4 49.5 13.9
1,502.0 15,473.4 857.1 187.5 31.0 20.6 82.5 15.4

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Suraksha Diagnostic

Suraksha Diagnostic Limited provides pathological and radiological services through diagnostic centers in India. It offers home collection services; pathology services, such as microbiology, serology, molecular biology, histopathology, cytopathology,...  clinical pathology, haematology, clinical biochemistry and immunology, immunohistochemistry, fluorescence in-situ hybridization, cytogenetics, flow cytometry, newborn screening, and NGS. The company also provides microarray, QF-PCR, FISH, karyotyping, and NIPT services; X-Ray, MRI scan, CT scan, USG, DEXA scan, Mammography, OPG radiology services; ECG, echocardiogram, stress test and treadmill test, wireless holter monitoring, and PFT cardiology services; EEG, EMG, and NCV neurology services; and upper GI and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy gastroenterology services. In addition, it offers clinic services, including dental, physiotherapy, immunology and rheumatology, ENT, eye, and specialty clinics, as well as fetal care; home doctor visit services; online doctor consultation; and doctor curated lab packages for bone and health, men's and women's health, senior citizens, diabetes care, fever, full-body checkups, and at-home packages. The company was founded in 1992 and is based in Kolkata, India. 

  • Incorporated

    2005

  • Chairman

    Somnath Chatterjee

  • Managing Director

    Somnath Chatterjee

  • Headquarters

    Kolkata, West Bengal

  • Website

    www.surakshanet.com

FAQs for Suraksha Diagnostic

The share price of Suraksha Diagnostic Ltd is ₹323.75 (NSE) and ₹324.05 (BSE) as of 11-Sep-2026 IST. Suraksha Diagnostic Ltd has given a return of 5.47% in the last 1 years.

The P/E ratio of Suraksha Diagnostic Ltd is 47.15 times as on 11-Sep-2026, a 22 discount to its peers’ median range of 60.28 times.
The P/B ratio of Suraksha Diagnostic Ltd is 6.58 times as on 11-Sep-2026, a 31 discount to its peers’ median range of 9.47 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2026
36.90
4.87
2025
42.19
6.36
2024
0.00
0.00
2023
0.00
0.00
2022
0.00
0.00

The 52-week high and low of Suraksha Diagnostic Ltd are Rs 349.00 and Rs 224.10 as of 12-Sep-2026.

Suraksha Diagnostic Ltd has a market capitalisation of ₹ 1,688 Cr as on 11-Sep-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Suraksha Diagnostic Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...